Globe Trade Centre Reappoints Supervisory Board Amidst 58.8% Stakeholder Backing

  • Globe Trade Centre S.A. reappoints three Supervisory Board members with extensive experience.
  • GTC Dutch Holdings B.V. holds a significant 58.80% stake, enabling board appointments.
  • Dr. Jรกnos Pรฉter Bartha, Bรกlint Szรฉcsรฉnyi, and Dr. Lรณrรกnt Dudรกs bring diverse expertise to GTC.

Globe Trade Centers SA

Globe Trade Centre S.A. (GTC) has announced the reappointment of three Supervisory Board members. The appointments were made by GTC Dutch Holdings B.V., a major shareholder.

Key Appointments

GTC received a written notice from GTC Dutch Holdings B.V. on June 24, 2024. The notice confirmed the reappointment of the following Supervisory Board members:

  1. Dr. Jรกnos Pรฉter Bartha
  2. Bรกlint Szรฉcsรฉnyi
  3. Dr. Lรณrรกnt Dudรกs

The reappointments will be effective from June 26, 2024.

Shareholder Details

GTC Dutch Holdings B.V. holds 337,637,591 shares in Globe Trade Centre S.A. This represents 58.80% of the company’s share capital. This significant shareholding gives GTC Dutch Holdings B.V. the right to appoint members of the Supervisory Board.

Appointment Criteria

The appointments were made according to Article 9 point 1 a)-c) of the company’s Articles of Association. This provision allows the entitled shareholder to appoint board members based on their shareholding percentage.

Qualifications of Appointed Members

Each appointed member has a distinguished professional background. They bring extensive experience in various fields relevant to GTC’s business.

Dr. Jรกnos Pรฉter Bartha

Dr. Jรกnos Bartha is an experienced investment banker. He has over 20 years of experience in private equity investments. His expertise includes privatization, IPOs, bond issues, and M&A transactions.

Career Highlights

  • 1982: Began career at National Bank of Hungary.
  • 1991: Became CEO of Credit Suisse First Boston in Hungary.
  • 1995: Appointed Managing Director for Central and Eastern Europe at Credit Suisse First Boston Ltd.

Dr. Bartha also founded his own investment company. His investments span multiple industries, including agroindustry, steel, construction, real estate, and fund management.

Independence Criteria

Dr. Bartha meets the independence criteria specified in Annex No. II to Commission Recommendation 2005/162/EC. This recommendation outlines the role of non-executive or supervisory directors of listed companies.

Bรกlint Szรฉcsรฉnyi

Bรกlint Szรฉcsรฉnyi is the CEO of Equilor Investment Ltd. He joined the Equilor Group in 2000 as a Corporate Finance Partner. Mr. Szรฉcsรฉnyi has more than 20 years of experience in securities issuances, syndicated loans, venture capital, and private equity transactions.

Career Highlights

  • 2000: Joined Equilor Group.
  • 2011-2015: Vice-president and member of the Board of the Budapest Stock Exchange.
  • Board Membership: Member of the Board of Richter Gedeon Pls.

Mr. Szรฉcsรฉnyi graduated from the Budapest University of Economics in 1998. He serves on the advisory board of the Faculty of Corporate Finance at the university.

Dr. Lรณrรกnt Dudรกs

Dr. Lรณrรกnt Dudรกs is the General Counsel and Board Member of Optima Investment Ltd. He joined Optima Investment Ltd. in 2016 and currently advises on real estate, corporate, commercial law, and investment matters.

Career Highlights

  • 2014-2016: Senior legal counsel at Takarรฉkbank Zrt.
  • 2011-2014: Senior attorney at CHSH Dezsล‘ & Partners International Law Firm.
  • 2007-2011: Provided legal support to an economic and financial agency for the Ministry of Defence.

Dr. Dudรกs graduated from the Faculty of Law of Eรถtvรถs Lorand University. He also studied economics and completed corporate compliance training.

Legal Compliance

According to their statements, none of the appointed members are listed in the register of insolvent debtors. They do not engage in any competitive activities against GTC. They are not partners in any competitive businesses or members of the authorities of any competing company.

Conclusion

The reappointment of Dr. Jรกnos Pรฉter Bartha, Bรกlint Szรฉcsรฉnyi, and Dr. Lรณrรกnt Dudรกs strengthens GTC’s Supervisory Board. Their extensive experience and qualifications will contribute to GTC’s ongoing success and governance.